These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 32929114

  • 1. Integrative genomic analysis of salivary duct carcinoma.
    Kim Y, Song S, Lee M, Swatloski T, Kang JH, Ko YH, Park WY, Jeong HS, Park K.
    Sci Rep; 2020 Sep 14; 10(1):14995. PubMed ID: 32929114
    [Abstract] [Full Text] [Related]

  • 2. Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer.
    Dalin MG, Desrichard A, Katabi N, Makarov V, Walsh LA, Lee KW, Wang Q, Armenia J, West L, Dogan S, Wang L, Ramaswami D, Ho AL, Ganly I, Solit DB, Berger MF, Schultz ND, Reis-Filho JS, Chan TA, Morris LG.
    Clin Cancer Res; 2016 Sep 15; 22(18):4623-33. PubMed ID: 27103403
    [Abstract] [Full Text] [Related]

  • 3. Genomic alteration in rare subtype of sarcomatoid salivary duct carcinoma.
    Jeong JS, Cho KJ, Kim D, Lee YS, Song JS.
    Pathol Res Pract; 2021 Dec 15; 228():153678. PubMed ID: 34781210
    [Abstract] [Full Text] [Related]

  • 4. The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement.
    Dogan S, Ng CKY, Xu B, Kumar R, Wang L, Edelweiss M, Scott SN, Zehir A, Drilon A, Morris LGT, Lee NY, Antonescu CR, Ho AL, Katabi N, Berger MF, Reis-Filho JS.
    Hum Pathol; 2019 Jun 15; 88():66-77. PubMed ID: 30946933
    [Abstract] [Full Text] [Related]

  • 5. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications.
    Santana T, Pavel A, Martinek P, Steiner P, Grossmann P, Baněčková M, Skálová A.
    Hum Pathol; 2019 Nov 15; 93():37-47. PubMed ID: 31437521
    [Abstract] [Full Text] [Related]

  • 6. High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.
    Ku BM, Jung HA, Sun JM, Ko YH, Jeong HS, Son YI, Baek CH, Park K, Ahn MJ.
    J Transl Med; 2014 Oct 25; 12():299. PubMed ID: 25343854
    [Abstract] [Full Text] [Related]

  • 7. Targeted molecular profiling of salivary duct carcinoma with rhabdoid features highlights parallels to other apocrine and discohesive neoplasms: which phenotype should drive classification?
    Rooper LM, Gagan J, Bishop JA.
    Head Neck Pathol; 2022 Dec 25; 16(4):1063-1072. PubMed ID: 35794510
    [Abstract] [Full Text] [Related]

  • 8. Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling.
    Gargano SM, Senarathne W, Feldman R, Florento E, Stafford P, Swensen J, Vranic S, Gatalica Z.
    Cancer Med; 2019 Dec 25; 8(17):7322-7329. PubMed ID: 31609094
    [Abstract] [Full Text] [Related]

  • 9. Molecular characterization of apocrine salivary duct carcinoma.
    Chiosea SI, Williams L, Griffith CC, Thompson LD, Weinreb I, Bauman JE, Luvison A, Roy S, Seethala RR, Nikiforova MN.
    Am J Surg Pathol; 2015 Jun 25; 39(6):744-52. PubMed ID: 25723113
    [Abstract] [Full Text] [Related]

  • 10. The implications of TrkA and MET aberrations in de novo salivary duct carcinoma.
    Ryu HJ, Koh YW, Yoon SO.
    Hum Pathol; 2018 Nov 25; 81():18-25. PubMed ID: 29753009
    [Abstract] [Full Text] [Related]

  • 11. The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunities.
    Alame M, Cornillot E, Cacheux V, Tosato G, Four M, De Oliveira L, Gofflot S, Delvenne P, Turtoi E, Cabello-Aguilar S, Nishiyama M, Turtoi A, Costes-Martineau V, Colinge J.
    Theranostics; 2020 Nov 25; 10(10):4383-4394. PubMed ID: 32292502
    [Abstract] [Full Text] [Related]

  • 12. Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment.
    Nardi V, Sadow PM, Juric D, Zhao D, Cosper AK, Bergethon K, Scialabba VL, Batten JM, Borger DR, Iafrate AJ, Heist RS, Lawrence DP, Flaherty KT, Bendell JC, Deschler D, Li Y, Wirth LJ, Dias-Santagata D.
    Clin Cancer Res; 2013 Jan 15; 19(2):480-90. PubMed ID: 23186780
    [Abstract] [Full Text] [Related]

  • 13. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications.
    Mitani Y, Rao PH, Maity SN, Lee YC, Ferrarotto R, Post JC, Licitra L, Lippman SM, Kies MS, Weber RS, Caulin C, Lin SH, El-Naggar AK.
    Clin Cancer Res; 2014 Dec 15; 20(24):6570-81. PubMed ID: 25316813
    [Abstract] [Full Text] [Related]

  • 14. Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic Alterations.
    Wang K, Russell JS, McDermott JD, Elvin JA, Khaira D, Johnson A, Jennings TA, Ali SM, Murray M, Marshall C, Oldham DS, Washburn D, Wong SJ, Chmielecki J, Yelensky R, Lipson D, Miller VA, Stephens PJ, Serracino HS, Ross JS, Bowles DW.
    Clin Cancer Res; 2016 Dec 15; 22(24):6061-6068. PubMed ID: 27334835
    [Abstract] [Full Text] [Related]

  • 15. Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy.
    Schmitt NC, Kang H, Sharma A.
    Oral Oncol; 2017 Nov 15; 74():40-48. PubMed ID: 29103750
    [Abstract] [Full Text] [Related]

  • 16. Whole-Genome Sequencing of Common Salivary Gland Carcinomas: Subtype-Restricted and Shared Genetic Alterations.
    Karpinets TV, Mitani Y, Liu B, Zhang J, Pytynia KB, Sellen LD, Karagiannis DT, Ferrarotto R, Futreal AP, El-Naggar AK.
    Clin Cancer Res; 2021 Jul 15; 27(14):3960-3969. PubMed ID: 34011559
    [Abstract] [Full Text] [Related]

  • 17. NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is "Intraductal" Correct?
    Skálová A, Ptáková N, Santana T, Agaimy A, Ihrler S, Uro-Coste E, Thompson LDR, Bishop JA, Baněčkova M, Rupp NJ, Morbini P, de Sanctis S, Schiavo-Lena M, Vanecek T, Michal M, Leivo I.
    Am J Surg Pathol; 2019 Oct 15; 43(10):1303-1313. PubMed ID: 31162284
    [Abstract] [Full Text] [Related]

  • 18. The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas.
    Skálová A, Stenman G, Simpson RHW, Hellquist H, Slouka D, Svoboda T, Bishop JA, Hunt JL, Nibu KI, Rinaldo A, Vander Poorten V, Devaney KO, Steiner P, Ferlito A.
    Am J Surg Pathol; 2018 Feb 15; 42(2):e11-e27. PubMed ID: 29076877
    [Abstract] [Full Text] [Related]

  • 19. Clinicopathological study of intraductal carcinoma of the salivary gland, with emphasis on the apocrine type.
    Hsieh MS, Lee YH, Jin YT, Kuo YJ.
    Virchows Arch; 2020 Oct 15; 477(4):581-592. PubMed ID: 32383006
    [Abstract] [Full Text] [Related]

  • 20. PIK3CA mutations and PTEN loss in salivary duct carcinomas.
    Griffith CC, Seethala RR, Luvison A, Miller M, Chiosea SI.
    Am J Surg Pathol; 2013 Aug 15; 37(8):1201-7. PubMed ID: 23851329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.